Otsuka Holdings (OTC:OTSKF) Stock, Quote.Headers.trade-ideas

Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.

AXSM

Analyst Color

Biotech

News

Health Care

Analyst Ratings

Trading Ideas

General

ITCI

OTSKF

OTSKY

Axsome&#39;s AXS-05 met endpoints in Alzheimer&#39;s agitation studies, showing long-term safety and tolerability. FDA filing planned for late 2025.

Axsome Reveals Data From Alzheimer&#39;s Studies, Analyst Sees Hope Despite Mixed Trial Results

cannabis CGC TLRY

Cannabis

IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer&#39;s agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo.

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer&#39;s-Associated Agitation

dementia-Photo by Gerd Altmann via Pixabay

Movers

IGC Pharma unveils interim results of Phase 2 trial of IGC-AD1 for Agitation in Alzheimer&#39;s Dementia. Shows reduction in agitation vs. placebo observed.

Alzheimer&#39;s-Focused Small Cap Firm IGC Pharma Releases Data,  Candidate Reduces Agitation Compared To Placebo

OTSUKA HOLDINGS CO LTD by Otsuka Holdings Co. Ltd.

Otsuka Holdings Co Ltd

Aristotle Global Equity Q3 2024 Commentary

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Holdings Co. has reported positive interim results from their Phase 3 trial of sibepren...

Otsuka's Promising Drug Advances in Kidney Disease Trial

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report), Otsuka Holdings Co (OTSKF – Rese...

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)

Artisan International Fund Q3 2024 Commentary

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Holdings Co. has announced changes in its leadership as part of its new medium-term man...

Otsuka Holdings Co. Announces Leadership Transition

Otsuka Holdings Co ( ($OTSKF) ) has released its Q3 earnings. Here is a breakdown of the information Otsuka Holdings Co presented to its investors....

Otsuka Holdings Reports Strong Nine-Month Financial Growth

Otsuka Holdings Co., Ltd. reports Q3 results

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Pharmaceutical Factory America, a subsidiary of Otsuka Pharmaceutical Factory, has part...

Otsuka Holdings Expands into North American IV Market

J.P. Morgan analyst Seiji Wakao maintained a Buy rating on Otsuka Holdings Co (OTSKF – Research Report) yesterday and set a price target of Yen11,8...

J.P. Morgan Remains a Buy on Otsuka Holdings Co (OTSKF)

Otsuka Holdings Co ( ($JP:4578) ) has provided an update. Otsuka Holdings has announced that the FDA plans to convene an advisory committee meeting...

Comments

Otsuka Holdings

Otsuka Holdings (OTSKF) Forecast

Otsuka Holdings (OTC:OTSKF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga